Nymbl Science, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-12.
Nymbl Science, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 12, 2025. The filing reports $984K sold. Its industry group is Other Health Care. It names Edward Likovich (Executive Officer, Director), David Eichler (Director), Meghan Oliver (Director) (SEC Form D, September 12, 2025).
Is this your company?
Sell to companies like Nymbl Science, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Nymbl Science, Inc.
Free to see. No signup.
More on the people and the money behind Nymbl Science, Inc., from the filings we hold.
Other Health Care raises by companies based in Colorado, filed within 90 days of this one, largest first.
Get an email when Nymbl Science, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Nymbl Science, Inc. raises, hires or launches. No email unless you switch it on.
Watch Nymbl Science, Inc. →Get the full cited report on Nymbl Science, Inc.
What the filing shows about Nymbl Science, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Nymbl Science, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Nymbl Science, Inc.'s address as 2000 S Colorado Blvd, Tower 2, Suite 320, Denver, CO 80222.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Nymbl Science, Inc. is a registered filer with the SEC (CIK 1781552) and has filed since 2022-12-01. 2 filings are on record, the latest on 2025-09-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Nymbl Science, Inc.'s Form D of 2025-09-12 names Edward Likovich, David Eichler, Meghan Oliver and 4 more as its officers, directors or promoters.
Its new offerings report $9.74M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 871 filings in Other Health Care, totalled by week.
Edward Likovich is named as Executive Officer and Director on the Form D that Nymbl Science, Inc. filed with the SEC on 12 September 2025, one of 7 people that filing names.
David Eichler is named as Director on the Form D that Nymbl Science, Inc. filed with the SEC on 12 September 2025, one of 7 people that filing names.
Meghan Oliver is named as Director on the Form D that Nymbl Science, Inc. filed with the SEC on 12 September 2025, one of 7 people that filing names.
Chris Saxman is named as Director on the Form D that Nymbl Science, Inc. filed with the SEC on 12 September 2025, one of 7 people that filing names.
Rohit Seth is named as Director on the Form D that Nymbl Science, Inc. filed with the SEC on 12 September 2025, one of 7 people that filing names.
Thomas Virden is named as Director on the Form D that Nymbl Science, Inc. filed with the SEC on 12 September 2025, one of 7 people that filing names.
Ben Wire is named as Director on the Form D that Nymbl Science, Inc. filed with the SEC on 12 September 2025, one of 7 people that filing names.
7 people named on the filing — 1 holding an executive role and 6 as directors only.
Named as of the 2025-09-12 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Nymbl Science, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Nymbl Science, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nymbl Science, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Nymbl Science, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Nymbl Science, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Nymbl Science, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in Denver and Boulder
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/nymbl-science-inc-form-d-25000001